How One Board-Certified Ophthalmologist Challenged the Status Quo on Documenting Risks for Retinal D
After 25 years in ophthalmology, busy Oregon-based glaucoma specialist J. Kevin McKinney, MD, had seen it all. But it was something the American Board of Ophthalmology diplomate didn’t see that troubled him — enough data on patients who could be at risk for retinal damage after taking hydroxychloroquine. So, with his team at Eye Health Northwest, Dr. McKinney set out to develop ways to better identify and monitor patients considered high-risk for retinal toxicity. To start, D